Your browser doesn't support javascript.
loading
A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide.
Schmidt, Keith T; Karzai, Fatima; Bilusic, Marijo; Cordes, Lisa M; Chau, Cindy H; Peer, Cody J; Wroblewski, Susan; Huitema, Alwin D R; Schellens, Jan H M; Gulley, James L; Dahut, William L; Figg, William D; Madan, Ravi A.
Afiliação
  • Schmidt KT; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Karzai F; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Bilusic M; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Cordes LM; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Chau CH; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Peer CJ; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Wroblewski S; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Huitema ADR; Department Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Schellens JHM; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Gulley JL; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Dahut WL; Utrecht Institute of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
  • Figg WD; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Madan RA; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Oncologist ; 27(9): 718-e694, 2022 09 02.
Article em En | MEDLINE | ID: mdl-35640474
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cistite / Nanopartículas / Neoplasias de Próstata Resistentes à Castração Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cistite / Nanopartículas / Neoplasias de Próstata Resistentes à Castração Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article